Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Gliosarcoma 1 Glioblastoma 1

Interventions

Temozolomide 85 Radiotherapy 51 Bevacizumab 31 Irinotecan 19 Radiation 16 Carmustine 15 Magnetic Resonance Spectroscopy 14 Erlotinib Hydrochloride 14 O(6)-benzylguanine 11 Chemotherapy, Adjuvant 11 Carboplatin 9 sargramostim 8 Thalidomide 8 Imatinib Mesylate 8 Filgrastim 8 Surgical Procedures, Operative 6 Gene Expression Profiling 6 Drug Therapy 6 pembrolizumab 5 aldesleukin 5 Topotecan 5 Radiotherapy, Intensity-Modulated 5 Hydroxyurea 5 Gefitinib 5 Etoposide 5 Sorafenib 4 Immunohistochemistry 4 Dasatinib 4 Celecoxib 4 Biopsy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Gliosarcoma × Sonication × Clear all

NCT04528680 2026-04-13

SC9/ABX

Northwestern University

Phase 1/2 Active not recruiting

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡